Mannatech Inc (MTEX) — Titan Protect Analysis

MTEX

Mannatech Inc

Consumer Defensive · ·

$5.70

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$10M

Total market value of the company

Trailing P/E

N/A

Forward P/E

N/A

Based on estimated future earnings — lower means cheaper

Rev Growth

-6.2%

Year-over-year revenue change

Profit Margin

-12.0%

How much profit the company keeps from each dollar of revenue

ROE

-1,253.9%

Return on equity — how efficiently it uses shareholder money

Analyst Target

N/A

Recommendation

NONE

Consensus view from ? analysts covering this stock

About Mannatech Inc

Mannatech, Incorporated operates as a wellness solution provider. The company develops markets and sells nutritional supplements; skin care and anti-aging products; and weight-management and fitness products. It primarily sells its products through network marketing distribution channels and e-commerce model. The company operates in the United States, Canada, Mexico, Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South

https://www.mannatech.com

Country: United States Employees: 170 Industry: Food Distribution

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.237

Positive but modest risk-adjusted returns

Kelly Fraction

-0.0869

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.189

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-14.2%

Historical annualised return based on price data

Max Drawdown

-74.9%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

N/A

52W High

$12.45

54% below the year high

52W Low

$3.80

50% above the year low

Avg Volume

29,979

Average daily shares traded — higher means easier to buy and sell

Short Ratio

0.9

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-6.71

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

N/A

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

75.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-0.7%

Profit from core operations before interest and tax

Free Cash Flow

$-850,125

Negative — the business is spending more than it generates

Revenue (TTM)

$106M

Total revenue over the last 12 months

Net Income

$-12,733,000

Loss-making — spending exceeds revenue after all costs

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go